Back to Results

A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of RMC-4630 Monotherapy in Adult Participants with Relapsed/Refractory Solid Tumors. Protocol v.1.3

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

In Expansion Arm, participants must have one of the following genotypic mutations: RTK mutation, amplification or re-arrangement; KRAS-G12, BRAF Class 3 or NF1 LOF mutation.

Phase

I - Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants.

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Jose Pacheco

Jose Pacheco

Study ID

Protocol Number: 18-1150

ClinicalTrials.gov: NCT03634982

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers